Author:
Hardinger Karen L.,Agha Irfan A.,Brennan Daniel C.
Publisher
Springer International Publishing
Reference155 articles.
1. Scientific Registry of Transplant Recipients (SRTR) and Organ Procurement and Transplantation Network (OPTN). SRTR/OPTN 2010 annual data report. Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation. Am J Transplant. 2012;12 Suppl 1.
2. Sansone F, Rinaldi M. Cyclosporine monotherapy in cardiac transplantation: review of the literature. Transplant Rev (Orlando). 2011;25(4):131–5.
3. Kamphues C, Bova R, Rocken C, Neuhaus R, Pratschke J, Neuhaus P, et al. Safety of mycophenolate mofetil monotherapy in patients after liver transplantation. Ann Transplant. 2009;14(4):40–6.
4. Nashan B, Moore R, Amlot P, Schmidt AG, Abeywickrama K, Soulillou JP. Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group. Lancet. 1997;350(9086):1193–8.
5. Kahan BD, Rajagopalan PR, Hall M. Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group. Transplantation. 1999;67(2):276–84.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献